Spectrum of zygomycete species identified in clinically significant specimens in the United States

Journal of Clinical Microbiology

Volumn 47, Issue 6, 2009, Pages 1650-1656

  Alvarez, E ^a   Sutton, D A ^b   Cano, J ^a   Fothergill, A W ^b   Stchigel, A ^a   Rinaldi, M G ^b   Guarro, J ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERNAL TRANSCRIBED SPACER; RIBOSOME DNA;

ABSIDIA; ARTICLE; CONTROLLED STUDY; CUNNINGHAMELLA BERTHOLLETIAE; CUNNINGHAMELLA ECHINULATA; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; LABORATORY TEST; LUNG; MUCOR; NONHUMAN; NUCLEOTIDE SEQUENCE; PARANASAL SINUS; PRIORITY JOURNAL; RHIZOMUCOR; RHIZOPUS; RHIZOPUS ORYZAE; SKIN; UNITED STATES; ZYGOMYCETES;

DNA, FUNGAL; DNA, RIBOSOMAL SPACER; FUNGI; HUMANS; MICROSCOPY; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; UNITED STATES; ZYGOMYCOSIS;

ABSIDIA CORYMBIFERA; APOPHYSOMYCES ELEGANS; CUNNINGHAMELLA BERTHOLLETIAE; CUNNINGHAMELLA ECHINULATA; FUNGI; MUCOR; MUCOR CIRCINELLOIDES; MUCOR INDICUS; MUCORALES; RHIZOMUCOR PUSILLUS; RHIZOPUS MICROSPORUS; RHIZOPUS ORYZAE; ZYGOMYCETES;

EID: 66749135249     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00036-09     Document Type: Article

References (40)

1. Almyroudis, N., D. Sutton, A. Fothergill, M. Rinaldi, and S. Kusne. 2007. In vitro susceptibilities of 217 clinical isolates of Zygomycetes to conventional and new antifungal agents. Antimicrob. Agents Chemother. 51:2587-2590.
2. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
3. Arnáiz-García, M. E., D. Alonso-Peña, M. C. González-Vela, J. D. García-Palomo, J. R. Sanz-Gimenéz- Rico, and A. M. Arnáiz-García. Cutaneous mucormycosis: report of five cases and review of the literature. J. Plast. Reconstr. Surg., in press.
4. Bal, A. M. 2006. Importance of identification of zygomycetes in the era of newer antifungal agents. Transpl. Infect. Dis. 8:122-123.
5. Balajee, S. A., A. M. Borman, M. E. Brandt, J. Cano, M. Cuenca-Estrella, E. Dannaoui, J. Guarro, G. Haase, C. C. Kibbler, W. Meyer, K. O'Donnell, C. A. Petti, J. L. Rodriguez-Tudela, D. Sutton, A. Velegraki, and B. L. Wickes. 2009. Sequence-based identification of Aspergillus, Fusarium and Mucorales in the clinical mycology laboratory: where are we and where should we go from here? J. Clin. Microbiol. 47:877-884.
6. de Hoog, G. S., J. Guarro, J. Gené, and M. J. Figueras. 2000. Atlas of clinical fungi, 2nd ed. Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands.
7. Diwakar, A., R. K. Dewan, A. Chowdhary, H. S. Randhawa, G. Khanna, and S. N. Gaur. 2007. Zygomycosis - a case report and overview of the disease in India. Mycoses 50:247-254. (Pubitemid 46920279)
8. Gilgado, F., J. Cano, J. Gené, and J. Guarro. 2005. Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species. J. Clin. Microbiol. 43:4930-4942.
9. Greenberg, R. N., L. J. Scott, H. H. Vaughn, and J. A. Ribes. 2004. Zygomycosis (mucormycosis): emerging clinical importance and new treatments. Curr. Opin. Infect. Dis. 17:517-525.
10. Hibbett, D. S., M. Binder, J. F. Bischoff, M. Blackwell, P. F. Cannon, O. E. Eriksson, S. Huhndorf, T. James, P. M. Kirk, R. Lucking, H. Thorsten Lumbsch, F. Lutzoni, P. B. Matheny, D. J. McLaughlin, M. J. Powell, S. Redhead, C. L. Schoch, J. W. Spatafora, J. A. Stalpers, R. Vilgalys, M. C. Aime, A. Aptroot, R. Bauer, D. Begerow, G. L. Benny, L. A. Castlebury, P. W. Crous, Y. C. Dai, W. Gams, D. M. Geiser, G. W. Griffith, C. Gueidan, D. L. Hawksworth, G. Hestmark, K. Hosaka, R. A. Humber, K. D. Hyde, J. E. Ironside, U. Koljalg, C. P. Kurtzman, K. H. Larsson, R. Lichtwardt, J. Longcore, J. Miadlikowska, A. Miller, J. M. Moncalvo, S. Mozley-Standridge, F. Oberwinkler, E. Parmasto, V. Reeb, J. D. Rogers, C. Roux, L. Ryvarden, J. P. Sampaio, A. Schussler, J. Sugiyama, R. G. Thorn, L. Tibell, W. A. Untereiner, C. Walker, Z. Wang, A. Weir, M. Weiss, M. M. White, K. Winka, Y. J. Yao, and N. Zhang. 2007. A higher-level phylogenetic classifi- cation of the fungi. Mycol. Res. 111:509-547.
11. Iwen, P. C., A. G. Freifeld, L. Sigler, and S. R. Tarantolo. 2005. Molecular identification of Rhizomucor pusillus as a cause of sinus-orbital zygomycosis in a patient with acute myelogenous leukaemia. J. Clin. Microbiol. 43:5819-5821.
12. Iwen, P. C., L. Sigler, R. K. Noel, and A. G. Freifeld. 2007. Mucor circinelloides was identified by molecular methods as a cause of primary cutaneous zygomycosis. J. Clin. Microbiol. 45:636-640.
13. Kontoyiannis, D. P., M. S. Lionakis, R. G. Lewis, G. Chamilos, M. Healy, C. Perego, A. Safdar, H. Kantarjian, R. Champlin, T. J. Walsh, and I. I. Raad. 2005. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J. Infect. Dis. 191:1350-1360.
14. Kontoyiannis, D. P., V. C. Wessel, G. P. Bodey, and K. V. I. Rolston. 2000. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin. Infect. Dis. 30:851-856.
15. Lemmer, K., H. Losert, V. Rickerts, G. Just-Nübling, A. Sander, M. Kerkmann, and K. Tintelnot. 2002. Molekularbiologische identifizierung von Cunninghamella spec. Mycoses 45:31-36.
16. Liang, K. P., I. M. Tleyjeh, W. R. Wilson, G. D. Roberts, and Z. Temesgen. 2006. Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans. J. Clin. Microbiol. 44:892-898.
17. Metellus, P., M. Laghmari, S. Fuentes, A. Eusebio, T. Adetchessi, S. Ranque, C. Bouvier, H. Dufour, and F. Grisoli. 2008. Successful treatment of a giant isolated cerebral mucormycotic (zygomycotic) abscess using endoscopic debridement: case report and therapeutic considerations. Surg. Neurol. 69:510-515.
18. Nucci, M., and K. A. Marr. 2005. Emerging fungal diseases. Clin. Infect. Dis. 41:521-526.
19. O'Donnell, K., F. M. Lutzoni, T. J. Ward, and G. L. Benny. 2001. Evolutionary relationships among mucoralean fungi (Zygomycota): evidence for family polyphyly on a large scale. Mycologia 93:286-296.
20. Oliver, M. R., W. C. Van Voorhis, M. Boeckh, D. Mattson, and R. A. Bowden. 1996. Hepatic mucormycosis in a bone marrow transplant recipient who ingested naturopathic medicine. Clin. Infect. Dis. 22:521-524.
21. Ribes, J. A., C. L. Vanover-Sams, and D. J. Baker. 2000. Zygomycetes in human disease. Clin. Microbiol. Rev. 13:236-301.
22. Robeck, T. R., and L. M. Dalton. 2002. Saksenaea vasiformis and Apophysomyces elegans zygomycotic infections in bottle nose dolphins (Tursiops truncates), a killer whale (Orcinus orca), and Pacific white-sided dolphins (Lagenorhynchus obliquidens). J. Zoo Wildl. Med. 33:356-366.
23. Roden, M. M., T. Z. Theoklis, W. L. Buchanan, T. A. Knudsen, T. A. Sarkisova, R. L. Schaufele, M. Sein, T. Sein, C. C. Chiou, J. H. Chu, D. P. Kontoyiannis, and T. J. Walsh. 2005. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin. Infect. Dis. 41:634-653.
24. Rogers, T. R. 2008. Treatment of zygomycosis: current and new options. J. Antimicrob. Chemother. 61:35-40.
25. Schipper, M. A. A. 1973. A study on variability in Mucor hiemalis and related species. Stud. Mycol. 4:1-40.
26. Schipper, M. A. A. 1976. On Mucor circinelloides, Mucor racemosus and related species. Stud. Mycol. 12:1-40.
27. Schipper, M. A. A. 1984. A revision of the genus Rhizopus. I. The Rhizopus stolonifer group and Rhizopus oryzae. Stud. Mycol. 25:1-19.
28. Schipper, M. A. A., and J. A. Stalpers. 1984. A revision of the genus Rhizopus. II. The Rhizopus microsporus group. Stud. Mycol. 25:20-34.
29. Schwarz, P., S. Bretagne, J.-C. Gantier, D. García-Hermoso, O. Lortholary, F. Dromer, and E. Dannaoui. 2006. Molecular identification of zygomycetes from culture and experimentally infected tissues. J. Clin. Microbiol. 44:340-349.
30. Sims, C. R., and L. Ostrosky-Zeichner. 2007. Contemporary treatment and outcomes of zygomycosis in a non-oncologic tertiary care center. Arch. Med. Res. 38:90-93.
31. Singh, J., D. Rimek, and R. Kappe. 2005. In vitro susceptibility of 15 strains of zygomycetes to nine antifungal agents as determined by the NCCLS M38-A microdilution method. Mycoses 48:246-250.
32. Spellberg, B., J. Edwards, and A. Ibrahim. 2005. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin. Microbiol. Rev. 18:556-569.
33. Tamura, K., J. Dudley, M. Nei, and S. Kumar. 2007. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24:1596-1599.
34. ter Borg, F., E. J. Kuijper, and H. van der Lelie. 1990. Fatal mucormycosis presenting as an appendiceal mass with metastatic spread to the liver during chemotherapy-induced granulocytopenia. Scand. J. Infect. Dis. 22:499-501.
35. Thompson, J. D., T. J. Gibson, F. Plewniak, F. Jeanmougin, and D. G. Higgins. 1997. The ClustalX windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 24:4876-4882. (Pubitemid 28022245)
36. Voigt, K., and J. Wöstemeyer. 2001. Phylogeny and origin of 82 zygomycetes from all 54 genera of the Mucorales and Mortierellales based on combined analysis of actin and translation elongation factor EF-1α genes. Gene 270:113-120.
37. Voigt, K., E. Cigelnik, and K. O'Donnell. 1999. Phylogeny and PCR identification of clinically important zygomycetes based on nuclear ribosomal-DNA sequence data. J. Clin. Microbiol. 37:3957-3964.
38. Walsh, T. J., A. Groll, J. Hiemenz, R. Fleming, E. Roilides, and E. Anaissie. 2004. Infections due to emerging and uncommon medically important fungal pathogens. Clin. Microbiol. Infect. 10:48-66.
39. White, M. M., T. Y. James, K. O'Donnell, M. J. Cafaro, Y. Tanabe, and J. Sugiyama. 2006. Phylogeny of the Zygomycota based on nuclear ribosomal sequence data. Mycologia 98:872-884.
40. Zycha, H., R. Siepmann, and G. Linnemann. 1969. Mucorales: eine beschreibungaller gattungen und arten dieser pilzgruppe, p. 355. Cramer, Lehre, Germany.